Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma

PHASE3CompletedINTERVENTIONAL
Enrollment

401

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions
Asthma
Interventions
DRUG

Placebo

2 actuations once daily in the evening

DRUG

Tiotropium low dose mcg

2 actuations once daily in the evening

DRUG

Tiotropium high dose

2 actuations once daily in the evening

Trial Locations (94)

Unknown

205.446.01014 Boehringer Ingelheim Investigational Site, Rolling Hills Estates

205.446.01011 Boehringer Ingelheim Investigational Site, Denver

205.446.01003 Boehringer Ingelheim Investigational Site, North Dartmouth

205.446.01009 Boehringer Ingelheim Investigational Site, Columbia

205.446.01005 Boehringer Ingelheim Investigational Site, Cincinnati

205.446.01010 Boehringer Ingelheim Investigational Site, Oklahoma City

205.446.01004 Boehringer Ingelheim Investigational Site, Charleston

205.446.01002 Boehringer Ingelheim Investigational Site, North Charleston

205.446.01012 Boehringer Ingelheim Investigational Site, Arlington

205.446.01013 Boehringer Ingelheim Investigational Site, San Antonio

205.446.54006 Boehringer Ingelheim Investigational Site, Buenos Aires

205.446.54002 Boehringer Ingelheim Investigational Site, Capital Federal

205.446.54003 Boehringer Ingelheim Investigational Site, Capital Federal

205.446.54008 Boehringer Ingelheim Investigational Site, Capital Federal

205.446.54005 Boehringer Ingelheim Investigational Site, Mar del Plata

205.446.54004 Boehringer Ingelheim Investigational Site, Mendoza

205.446.54007 Boehringer Ingelheim Investigational Site, San Miguel de Tucumán

205.446.61003 Boehringer Ingelheim Investigational Site, Herston

205.446.61001 Boehringer Ingelheim Investigational Site, Perth

205.446.32004 Boehringer Ingelheim Investigational Site, Antwerp

205.446.32005 Boehringer Ingelheim Investigational Site, Bruges

205.446.32006 Boehringer Ingelheim Investigational Site, Namur

205.446.55001 Boehringer Ingelheim Investigational Site, Curitiba

205.446.55007 Boehringer Ingelheim Investigational Site, Goiânia

205.446.55006 Boehringer Ingelheim Investigational Site, Porto Alegre

205.446.55002 Boehringer Ingelheim Investigational Site, São Paulo

205.446.55003 Boehringer Ingelheim Investigational Site, São Paulo

205.446.55004 Boehringer Ingelheim Investigational Site, São Paulo

205.446.55005 Boehringer Ingelheim Investigational Site, São Paulo

205.446.02003 Boehringer Ingelheim Investigational Site, London

205.446.02001 Boehringer Ingelheim Investigational Site, Sherbrooke

205.446.42005 Boehringer Ingelheim Investigational Site, Jablonec nad Nisou

205.446.42001 Boehringer Ingelheim Investigational Site, Jihlava

205.446.42002 Boehringer Ingelheim Investigational Site, Prague

205.446.42004 Boehringer Ingelheim Investigational Site, Prague

205.446.49012 Boehringer Ingelheim Investigational Site, Berlin

205.446.49015 Boehringer Ingelheim Investigational Site, Berlin

205.446.49001 Boehringer Ingelheim Investigational Site, Bochum

205.446.49007 Boehringer Ingelheim Investigational Site, Dresden

205.446.49003 Boehringer Ingelheim Investigational Site, Frankfurt

205.446.49009 Boehringer Ingelheim Investigational Site, Koblenz

205.446.49014 Boehringer Ingelheim Investigational Site, Marburg

205.446.49011 Boehringer Ingelheim Investigational Site, Mönchengladbach

205.446.50201 Boehringer Ingelheim Investigational Site, Guatemala City

205.446.50202 Boehringer Ingelheim Investigational Site, Guatemala City

205.446.50203 Boehringer Ingelheim Investigational Site, Guatemala City

205.446.50204 Boehringer Ingelheim Investigational Site, Guatemala City

205.446.36002 Boehringer Ingelheim Investigational Site, Ajka

205.446.36001 Boehringer Ingelheim Investigational Site, Budapest

205.446.36003 Boehringer Ingelheim Investigational Site, Nagyatád

205.446.36004 Boehringer Ingelheim Investigational Site, Szeged

205.446.37105 Boehringer Ingelheim Investigational Site, Baldone

205.446.37104 Boehringer Ingelheim Investigational Site, Balvi

205.446.37108 Boehringer Ingelheim Investigational Site, Daugavpils

205.446.37107 Boehringer Ingelheim Investigational Site, Jēkabpils

205.446.37101 Boehringer Ingelheim Investigational Site, Ogre

205.446.37106 Boehringer Ingelheim Investigational Site, Rēzekne

205.446.37102 Boehringer Ingelheim Investigational Site, Riga

205.446.37103 Boehringer Ingelheim Investigational Site, Riga

205.446.37004 Boehringer Ingelheim Investigational Site, Šiauliai

205.446.37003 Boehringer Ingelheim Investigational Site, Tauragė

205.446.37002 Boehringer Ingelheim Investigational Site, Utena

205.446.37001 Boehringer Ingelheim Investigational Site, Vilnius

205.446.48004 Boehringer Ingelheim Investigational Site, Bialystok

205.446.48002 Boehringer Ingelheim Investigational Site, Lodz

205.446.48001 Boehringer Ingelheim Investigational Site, Lublin

205.446.48003 Boehringer Ingelheim Investigational Site, Tarnów

205.446.40002 Boehringer Ingelheim Investigational Site, Bucharest

205.446.70002 Boehringer Ingelheim Investigational Site, Moscow

205.446.70005 Boehringer Ingelheim Investigational Site, Moscow

205.446.70007 Boehringer Ingelheim Investigational Site, Moscow

205.446.70011 Boehringer Ingelheim Investigational Site, Moscow

205.446.70012 Boehringer Ingelheim Investigational Site, Novosibirsk

205.446.70001 Boehringer Ingelheim Investigational Site, Saint Petersburg

205.446.70003 Boehringer Ingelheim Investigational Site, Saint Petersburg

205.446.70004 Boehringer Ingelheim Investigational Site, Saint Petersburg

205.446.70010 Boehringer Ingelheim Investigational Site, Saint Petersburg

205.446.70009 Boehringer Ingelheim Investigational Site, Yaroslavl

205.446.42101 Boehringer Ingelheim Investigational Site, Košice

205.446.42103 Boehringer Ingelheim Investigational Site, Prešov

205.446.42102 Boehringer Ingelheim Investigational Site, Spišská Nová Ves

205.446.38013 Boehringer Ingelheim Investigational Site, Chernivtsi

205.446.38002 Boehringer Ingelheim Investigational Site, Dnipropetrovsk

205.446.38003 Boehringer Ingelheim Investigational Site, Dnipropetrovsk

205.446.38005 Boehringer Ingelheim Investigational Site, Donetsk

205.446.38012 Boehringer Ingelheim Investigational Site, Donetsk

205.446.38009 Boehringer Ingelheim Investigational Site, Kharkiv

205.446.38004 Boehringer Ingelheim Investigational Site, Kiev

205.446.38006 Boehringer Ingelheim Investigational Site, Kryvyi Rih

205.446.38001 Boehringer Ingelheim Investigational Site, Lviv

205.446.38014 Boehringer Ingelheim Investigational Site, Odesa

205.446.38010 Boehringer Ingelheim Investigational Site, Vinnytsia

205.446.38011 Boehringer Ingelheim Investigational Site, Zaporizhya

205.446.38008 Boehringer Ingelheim Investigational Site, Zaporizhzhya

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Boehringer Ingelheim

INDUSTRY